期刊文献+

HPLC手性固定相法拆分丁苯酞及其衍生物对映体 被引量:3

Enantioseparation of 3-n-Butylphthalide and 6-Br-3-n-butylphthalide on Chiralpak IC Column by HPLC
原文传递
导出
摘要 目的建立丁基苯酞(3-n-butylphthalide,NBP)及其衍生物6-Br-NBP的手性HPLC拆分方法。方法以纤维素-三(3,5-二氯苯基氨基甲酸酯)为固定相的手性Chiralpak IC柱,系统研究NBP及其衍生物6-Br-NBP在HPLC系统中的拆分,分别考察流动相改性剂、柱温、流动相流速等对拆分效果的影响。结果当流动相为正己烷-无水乙醇(98∶2)、流速为0.8 mL·min·1、柱温为35℃时,NBP的分离因子α和分离度Rs分别为1.07和2.20。当流动相为正己烷∶异丙醇(70∶30)、流速为0.8 mL·min·1、柱温为20℃时,6-Br-NBP的分离因子α和分离度Rs分别为1.10和2.67。结论该方法适用于NBP及其类似衍生物对映体的拆分。 OBJECTIVE To establish method for enantioseparation of 3-n-butylphthalide(NBP) and 6-Br-NBP on Chiralpak IC column by HPLC. METHODS HPLC had been developed for the chiral separation of NBP and 6-Br-NBP on a Chiralpak IC column under normal phase mode. The influences of organic solvent, column temperature and flow rate were investigated and the enatiomeric separation was optimized systematically. RESULTS NBP and 6-BroNBP could be separated completely. In the circumstance of hexane-ethanol(98 :2), flow rate 0.8 mL.min-1, temperature 35 ℃, to NBP, the separation factor α was 1.07 and the resolution Rs reached 2.20. As hexane-isopropanol(70 : 30), flow rate 0.8 mL·min^-1, injection volume 10 μL, temperature 20 ℃, to 6-Br-NBP, the separation factor α was 1.10 and the resolution Rs reached 2.67. CONCLUSION This method is suitable for the chiral separation of NBP and 6-Br-NBP.
出处 《中国现代应用药学》 CAS CSCD 2014年第3期335-338,共4页 Chinese Journal of Modern Applied Pharmacy
关键词 丁基苯酞 高效液相色谱法 ChiralpakIC 3-n-butylphthalide HPLC Chiralpak IC
  • 相关文献

参考文献2

二级参考文献7

  • 1冯亦璞,药学学报,1995年,30卷,741页
  • 2胡盾,药学学报,1996年
  • 3黄新祥,药学学报,1996年
  • 4刘小光,药学学报,1995年,30卷,896页
  • 5李卫平,药学学报,1994年,29卷,721页
  • 6于澎仁,药学学报,1984年,19卷,566页
  • 7冯亦璞,药学学报,1995年,30卷,741页

共引文献79

同被引文献23

  • 1王永秋,赵慧.高效液相色谱-二极管阵列检测法测定L-丙氨酸与L-氨基丙醇[J].分析试验室,2010,29(9):44-46. 被引量:4
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33022
  • 3陈仲益,姚彤炜,曾苏.CHIRALPAK AD柱在14种药物手性分离中的应用[J].中国药学杂志,2007,42(7):544-547. 被引量:16
  • 4ZHANG Z G, ZHANG L, JIANG Q, et al. Bone marrow- derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemic in the adult mouse [ J ]. Circ Res, 2002,90 ( 3 ) : 284- 288.
  • 5ZHAO Y H,YUAN B,CHEN J,et al.Endothelial progenitorcells : therapeutic perspective for ischemic stroke [ J ]. CNS Neurosci Ther,2013,19(2) :67-75.
  • 6SOBRINO T,HURTADO O, MORO M A,et al.The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome [ J ]. Stroke, 2007,38(10) :2759-2764.
  • 7KANEKO Y, TAJIRI N, SHINOZUKA K, et al. Cell therapy for stroke:emphasis on optimizing safety and efficacy profile of endothelial progenitor ceils [ J ].Curr Pharm Des, 2012,18 ( 25 ) : 3731- 3734.
  • 8YIP H K,CHANG L T,CHANG W N,et al.Level and value of circulating endothelial progenitor cells in patients after ischemic stroke [ J ]. Stroke, 2008,39 ( 1 ) : 69- 74.
  • 9BOGOSLOVSKY T, SPATZ M, CHAUDHRY A, et al. Stro- mal-derived factor-let correlates with circulating endothlial progenitor cells and with acute lesion volume in stroke patients [ J ]. Stroke, 2011,42 ( 3 ) : 618- 625.
  • 10YU J X, HUANG X F, LYU M, et al. Combination of stro- mal-derived factor-let and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization [ J ]. J Vase Surg, 2009,50 (3) :608-616.

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部